CNBC’s Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report.

Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...

The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease ...

The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate ...

The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...

U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year. The World ...